Between 2015 and 2019, HER2 testing was done on 5,305 patients with diverse cancers (N = 3,926 were tested for CNV, N = 1,848 were tested for mRNA, and N = 2,533 were tested by IHC. The gene discussed is ERBB2; the disease is cancer.